- Home
- TRSG vs COEP Comparison
TRSG vs COEP Comparison
Compare TRSG & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- COEP
- Stock Information
- Founded
- TRSG 1996
- COEP 2017
- Country
- TRSG Singapore
- COEP United States
- Employees
- TRSG N/A
- COEP N/A
- Industry
- TRSG
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRSG
- COEP Health Care
- Exchange
- TRSG NYSE
- COEP Nasdaq
- Market Cap
- TRSG 27.0M
- COEP 32.0M
- IPO Year
- TRSG 2024
- COEP N/A
- Fundamental
- Price
- TRSG $1.73
- COEP $7.48
- Analyst Decision
- TRSG
- COEP
- Analyst Count
- TRSG 0
- COEP 0
- Target Price
- TRSG N/A
- COEP N/A
- AVG Volume (30 Days)
- TRSG 8.4K
- COEP 31.9K
- Earning Date
- TRSG 05-14-2025
- COEP 08-15-2025
- Dividend Yield
- TRSG N/A
- COEP N/A
- EPS Growth
- TRSG N/A
- COEP N/A
- EPS
- TRSG N/A
- COEP N/A
- Revenue
- TRSG $12,810,249.00
- COEP $62,874.00
- Revenue This Year
- TRSG N/A
- COEP N/A
- Revenue Next Year
- TRSG N/A
- COEP N/A
- P/E Ratio
- TRSG N/A
- COEP N/A
- Revenue Growth
- TRSG N/A
- COEP N/A
- 52 Week Low
- TRSG $1.00
- COEP $2.31
- 52 Week High
- TRSG $4.57
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- COEP 39.31
- Support Level
- TRSG N/A
- COEP $7.21
- Resistance Level
- TRSG N/A
- COEP $8.86
- Average True Range (ATR)
- TRSG 0.00
- COEP 0.59
- MACD
- TRSG 0.00
- COEP -0.03
- Stochastic Oscillator
- TRSG 0.00
- COEP 32.98
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.